Inside this issue
Download this whole issue as a PDF file
|
|
Grants and contracts awarded to Yale School of Medicine, May/June 2005
Federal
- Vikki Abrahams, NIH, Innate Immune Responses of
Trophoblasts in Pregnancy,
5 years, $1,375,632
- Anton Bennett, NIH, Myogenesis by Protein Tyrosine
Phosphatases, 5 years, $1,798,500
- Hilary Blumberg, NIH, Genetics
of Hippocampal Deficits in Bipolar Disorder, 5 years, $1,704,534
- Kathleen Carroll, NIH, Maximizing CBT’s Efficacy with
Medication and CM, 5 years, $1,700,294
- Tian Chi, NIH, BAF Complexes
in T Cell Development and Beyond, 5 years, $1,982,438
- Jonathan Dranoff, NIH, Regulation of Bile Ductular
Proliferation, 5 years, $1,675,875
- Gerald Friedland, NIH, New England Program for AIDS
Clinical Trial-PROACT,
1 year, $802,492
- Xiao-Bing Gao, NIH, Crosstalk of Hypocretin
and MCH in Feeding Regulation, 5 years, $1,697,814
- Sankar Ghosh, NIH, Regulation of NF-κΒ Transcriptional
Activity, 5 years, $1,982,438
- Karl Insogna, NIH, Role of CSF-1
in Osteoclast Function, 4 years, $1,466,995
- Akiko Iwasaki, NIH, Antiviral CTL Mobilization to
the Genital Mucosa, 5 years, $1,982,438
- Susan Kaech, NIH, Regulation of Memory CD8 T
Cell Development, 5 years, $1,982,438
- Harriet Kluger, NIH, Predicting Melanoma Response to
BAY 43-9006/Chemotherapy,
4 years, $1,150,267
- Brian Leaderer, NIH, Indoor and Outdoor NO2 and Asthma
Severity in Children, 5
years, $403,509
- Thomas McGlashan, NIH, Collaborative Longitudinal Study
of Personality Disorder,
4 years, $1,005,782
- Sherry McKee, NIH, Negative Affect and Smoking Behavior
in Women and Men, 2 years,
$394,885
- Sukanya Narasimhan, NIH, Early Tick Salivary Antigens
as Vaccine Targets, 2 years, $440,100
- Godfrey Pearlson, NIH, fMRI Imaging of Alcohol-Intoxicated
Driving, 4 years, $973,672
- Vincent Quagliarello, NIH, Intervention Planning to
Reduce Nursing Home Pneumonia, 1 year, $165,356
- David Rimm, NIH, Predicting Metastasis to Lymph Nodes, 4 years,
$1,033,320
- Michael Robek, NIH, Modulation of HBV Replication by
the Immunoproteasome, 2
years, $268,000
- Gerard Sanacora, NIH, 13C Measurement of GABA Synthesis
in Depression, 5 years, $1,698,705
- David Schatz, NIH, Targeting of Somatic
Hypermutation and Gene Conversion, 2 years, $449,625
- Albert Shaw, NIH, Top3 Homologues in Lymphocyte Genome
Stability and Aging, 5 years, $355,175
- David Stern, NIH, Protein Kinases in Yeast DNA Checkpoint
Pathways,
5 years, $1,364,264
- Brian Wong, NIH, Mechanisms of Drug Resistance
in Candida albicans, 3 years, $968,420
 |
With funding from the National Institutes of Health, Akiko Iwasaki, assistant professor of immunobiology, studies immune responses to herpes simplex virus type 2 (HSV-2) infection, one of the most common sexually transmitted diseases. In this section of mouse vaginal tissue, immune-system cells (green) are seen in proximity to cells infected with HSV-2 (red).
|
Non-Federal
- Diana Beardsley, RAM Capital Group, LLC, Perinatal
Immune Thrombocytopenia,
1 year, $239,766
- Alfred Bothwell, L2 Diagnostics, LLC, Protection
Against West Nile Virus by RNA Interference, 2 years, $292,188
- Janet Brandsma,
Anacor Pharmaceuticals, Screening Anacor Compounds for in
vivo Efficacy in the Cottontail Rabbit Papillomavirus (CRPV)
Assay,
1 year, $151,952
- Michael Cappello, University of California
- San Diego, Function/Optimization of a Nematicidal Cry
Toxin Arsenal, 4 years, $23,643
- Sonia Caprio, Children’s Hospital,
Boston, Health Values and Treatment of Pediatric Type
2 Diabetes, 1 year, $1,890
- Idil Cavus, The Epilepsy Project, Controlling
Brain Excitability by Electrical Stimulation, 1 year,
$100,000
- Gina Chung, Susan G. Komen Breast Cancer Foundation,
The Role of Chemokines and Their Receptors in Breast
Cancer, 3 years, $249,999
- R. Todd Constable, Pfizer
Inc., Magnetic Resonance Imaging for Non-Invasive
Characterization of Liver Fibrosis, Cirrhosis,
and Hemodynamics with Application to Other Organs,
1 year, $356,127
- Ronald Duman, Organon Inc., Influence
of Org 2448 and Org 26576 on Neurogenesis in Adult Hippocampus, 1 year, $221,160; National
Alliance for Research on Schizophrenia and
Depression, Proliferation and Survival of
Glia: Regulation by Stress and Antidepressants,
1 year, $100,000
- John Geibel, AstraZeneca,
A.B., Multi-Tissue Analysis of AstraZeneca’s
Compound Coded as AZD0865, 6 months, $150,722
- Joel Gelernter,
Medical University of South Carolina, Florida Hurricanes
and Older Adults: Outcomes/Resiliency, 2 years, $13,040
- Harriet Kluger, Breast Cancer Alliance Inc., Prediction
of Lymph Node Involvement in Breast Cancer, 2 years,
$60,000
- Harlan Krumholz, Mid America Heart
Institute,
SCCOR in Cardiac Dysfunction and Disease-Project
4, 4 years, $114,524
- Daniel Mathalon, American
Psychiatric Association, APIRE/Kemp Fund
Award for Research, 2 years, $21,500
- Russell Matthews,
University of Georgia, GicNAcT-V Regulation
of Cell Surface Structure/Function, 5 years,
$100,757
- Linda Mayes, Community Foundation
for Greater New Haven, Minding
the Baby Home Visiting Program for
First-Time Parents, 1 year, $20,000
- Diane McMahon-Pratt,
Fort Dodge Animal Health Division
of Wyeth, Visceral Leishmaniasis
Vaccine Efficacy in Intradermal
BALB/C Mouse Model, 2 years, $115,000
- Wang Min, AtheroGenics Inc.,
AtheroGenics Testing Agreement,
1 year, $45,000
- Guillermo
Mor, Wayne State University, Studies
of Toll-Like Receptors
and Apoptosis in the Maintenance
of Innate Immunity During
Pregnancy, 1 year, $133,854
- Alexander Neumeister,
Anxiety Disorders Association
of America, Genetic
Determinants of Noradrenergic
Function in Panic Disorder,
1 year, $30,000
- Scott
Rivkees, March
of Dimes, Prevention of Brain
Injury of Prematurity
by Prenatal Adenosine Antagonists, 1 year, $264,779
- Sara
Rockwell, Susan G. Komen Breast Cancer Foundation, Interactions
of Black Cohosh Extracts
with Doxorubicin: Possible Mechanisms, 2 years, $250,000
- Nenad Sestan, March of Dimes, Molecular
and Cellular Characterization of Dominant Ataxia with Hydrocephalus
in the Clumsy Mutant Mouse, 3 years, $229,014
- Mark Solomon, March of Dimes, Substrates
of the Anaphase Promoting Complex, 3 years, $263,652
- Stephen
Strittmatter, Dr. Ralph and Marian Falk Medical
Research Trust, Axonal Regeneration Therapy
for Spinal Cord Injury, 3 years, $975,000
- Patrick
Sung, Susan G. Komen Breast Cancer Foundation,
Role of BRCA2 in Homology-Directed
Repair of DNA Breaks, 2 years, $250,000
- Agnes
Vignery, Unigene Laboratories Inc.,
Targeted Induction of Bone Formation in vivo, 3 years, $739,360
- Fred Volkmar,
Oregon Health Sciences University,
Measuring Expressive and Receptive
Prosody in Children with Autism,
4 years, $137,670
- Sherman Weissman,
University of Massachusetts,
Gene Expression in Mature
Neutrophils,
4 years, $285,618
- Jason Wilken,
Elsa U. Pardee Foundation, Inhibitory
Potential of SErbB3: A
Soluble ErbB3 Isoform, 1 year, $30,000
- Scott Woods,
National Alliance for Research on Schizophrenia and Depression,
Glycine vs. Placebo in Patients with Schizophrenia, 1 year,
$100,000
- Derek Yach, Open Society Institute, Reducing Deaths
from Tuberculosis and Tobacco Together, 1 year, $70,000
|
